Related Experiment Video
Updated: Jan 1, 2026
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
STAT5: From Pathogenesis Mechanism to Therapeutic Approach in Acute Leukemia
Mohammad Shahjahani1, Amirreza Abroun2, Najmaldin Saki1
1Thalassemia and Hemoglobinopathy Research Center, Research Institute of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Background:
Based on the results of multiple studies, multiple signaling pathways is a major cause of resistence to chemotherapy in leukemia cells. Signal transducer and activator of transcription 5 (STAT5) is among these factors; it plays an essential role in proliferation of leukemic cells.
Methods:
We obtained the materials used in our study via PubMed search from 1996 through 2019. The key search terms included "STAT5," "acute leukemia," "leukemogenesis," and "mutation."
Results:
On activation, STAT5 not only inhibits apoptosis of leukemic cells via activating the B-cell lymphoma 2 (BCL-2) gene but also inhibits resistance to chemotherapy by enhancing human telomerase reverse transcriptase (hTERT) expression and maintaining telomere length in cells. It has also been shown that a number of mutations in the STAT5 gene and in related genes alter the expression of STAT5.
Conclusion:
The identification of STAT5 and the factors activated in its up- or downstream expression, affecting its function, contribute to better treatments such as targeted therapy rather than chemotherapy, improving the quality of life patients.
Insights
Signal transducer and activator of transcription 5 (STAT5) promotes leukemia cell survival and chemotherapy resistance. Targeting STAT5 offers a promising avenue for developing more effective leukemia treatments.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Multiple signaling pathways contribute to chemotherapy resistance in leukemia.
- Signal transducer and activator of transcription 5 (STAT5) is crucial for leukemic cell proliferation.
Purpose of the Study:
- To investigate the role of STAT5 in leukemia cell survival and chemotherapy resistance.
- To explore the potential of targeting STAT5 for improved leukemia treatment.
Main Methods:
- Literature review of studies published between 1996 and 2019.
- PubMed search using keywords: "STAT5," "acute leukemia," "leukemogenesis," and "mutation."
Main Results:
- Activated STAT5 inhibits apoptosis by upregulating B-cell lymphoma 2 (BCL-2).
- STAT5 enhances chemotherapy resistance by increasing human telomerase reverse transcriptase (hTERT) expression and maintaining telomere length.
- Mutations in STAT5 and related genes can alter STAT5 expression.
Conclusions:
- Identifying STAT5 and its regulatory factors is key to developing targeted therapies.
- Targeted therapies focusing on STAT5 may offer superior outcomes compared to traditional chemotherapy.
- Understanding STAT5 pathways can improve patient quality of life in leukemia treatment.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
01:27Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
01:31The Intrinsic Apoptotic Pathway